Hanukkah, characterized by Adam Sandler as
Eight Crazy Nights
, ends this evening. Tomorrow, baring a miracle, eight mad weeks of
US stock market gains will similarly come to a close. It was
lights-out in equities for a fourth straight session as indices
endured their first four-session losing slump since late September.
Fed taper fears emerged again amid strong economic data, not least
the fastest monthly increase in new-home sales since 1980. That
truly was an unfathomably distant era, when
still rolled off the printing presses
vied for headlines with
. We really have come a long way since the early '80s, when
was a box-office sensation. Indeed yesterday's top
(INDEXNASDAQ:.IXIC) stock was
Oculus Innovative Sciences
), which surged 103.43% on approval for its anti-scar gel.
), whose founder was born in 1984 - and (Big) Brother, is he ever a
big believer in
- gained 4.04% on speculation it is shortly to be added to the
S&P 500 Index
(INDEXSP:.INX). Although, really, why would it want to be included
in such a club?
) was that benchmark's top stock in November before being
unceremoniously booted. And
), up another 2.29% yesterday, has been on a tear since getting
In terms of economic events that may move US markets today, at
10:00 a.m. Eastern consensus calls for a fall in October factory
orders. Regarding specific stocks,
Jos A Bank
Pacific Sunwear of California
Royal Bank of Canada
(ZUMZ) are all due to release quarterly results.
(ADI): Shares are assigned an Outperform at Oppenheimer, whose
target price is $58.
(ARRS): Brean Capital covers the company at a Buy.
(BSX): The Benchmark Company has a Hold on Boston Scientific. Its
target is $12 on the stock.
(COV): Shares are initiated with a Buy opinion and $82 price
objective at Benchmark Company, which cites its impressive efforts
at diversification among other favorable factors.
(EBAY): If it's Thursday, it must be an eBay initiation. After an
upgrade on Monday
downgrade on Wednesday
, the online auctioneer is today assigned a fresh Fair Value at CRT
(MTG): Goldman Sachs starts the stock at a Conviction Buy with a
target of $10.
has Oracle's billionaire CEO Larry Ellison in mind, although for
all I know Larry Summers is also long the stock.) The tech name is
a new Outperform at BMO Capital. Its price objective on Oracle is
(PSEC): Shares are a Hold with Wunderlich.
(RDN): Goldman resumes Buy-rated research, and a $17 target price,
Raymond James Financial
(RJF): Buckingham Research starts the stock at a Buy.
(SPR): Shares are showing strength ahead of the open after being
begun with a Buy at Citigroup.
(SPN): JPMorgan starts the stock at Overweight.
: BMO establishes Outperforms on
(RHT). Its respective price objectives are $65, $105, and $55.
Stock Upgrades: Tiffany Running Rings Around the
Stock Downgrades: Oil's Not Well at Exxon